Table 3 Comparison between the malignancy and non-malignancy groups
Serum component | Malignancy group | Non-malignancy group | p |
|---|---|---|---|
CRP (mg/dl) | 5.33 ± 4.37 | 4.54 ± 6.70 | 0.488 |
eGFR (ml/min/1.73 m2) | 60.56 ± 31.42 | 45.97 ± 29.08 | 0.024 |
Total protein (g/dl) | 6.08 ± 0.60 | 6.06 ± 1.27 | 0.889 |
LDH (U/L) | 543.35 ± 767.60 | 357.98 ± 186.54 | 0.138 |
Albumin (g/dl) | 3.01 ± 0.46 | 3.11 ± 0.75 | 0.399 |
Glucose (mg/dl) | 142.20 ± 61.03 | 134.10 ± 53.05 | 0.518 |
Hemoglobin (g/dl) | 11.01 ± 1.77 | 11.11 ± 1.60 | 0.766 |
Hematocrit (%) | 33.29 ± 5.61 | 34.24 ± 4.84 | 0.391 |
BNP (pg/ml) | 126.89 ± 183.35 | 409.18 ± 868.67 | 0.037 |
Pericardial fluid component | |||
Ph | 7.39 ± 0.20 | 7.48 ± 0.12 | 0.069 |
Total protein (g/dl) | 5.02 ± 0.80 | 4.72 ± 1.19 | 0.166 |
LDH (U/L) | 2032.10 ± 3522.33 | 1029.58 ± 1561.52 | 0.106 |
Albumin (g/dl) | 2.66 ± 0.53 | 2.61 ± 0.70 | 0.661 |
Glucose (mg/dl) | 78.24 ± 48.29 | 98.41 ± 44.85 | 0.048 |
ADA (U/L) | 37.59 ± 47.26 | 29.34 ± 37.66 | 0.389 |
Hyaluronic acid (ng/ml) | 31,975.9 ± 27,282.7 | 27,194.6 ± 28,745.9 | 0.438 |
Hemoglobin (g/dl) | 3.83 ± 2.22 | 5.15 ± 5.19 | 0.422 |
Hematocrit (%) | 14.79 ± 6.73 | 16.74 ± 21.36 | 0.788 |
Variable | |||
Pericardial fluid/serum ratio | |||
Total protein ratio | 0.83 ± 0.14 | 0.78 ± 0.15 | 0.127 |
LDH ratio | 5.23 ± 7.69 | 2.59 ± 2.71 | 0.047 |
Glucose ratio | 0.57 ± 0.34 | 0.83 ± 0.45 | 0.005 |
Pericardial fluid/Serum total protein ratio > 0.5 | 49 (100%) | 38 (97.4%) | 0.260 |
Pericardial fluid/Serum LDH ratio > 0.6 | 47 (94.0%) | 29 (76.3%) | 0.017 |
Pericardial fluid LDH > 2/3 UNL | 49 (98.0%) | 32 (86.5%) | 0.036 |
Cytology, positive | 43 (76.8%) | − | − |